In May 2026 the American owner of Ukraine's largest life insurer agreed to sell it. MetLife Ukraine held close to half its market, served around 900,000 customers and was profitable, and the price has not been disclosed. That transaction corrects two assumptions common in ownership discussions about Ukraine. Foreign owners do sell, including businesses that work well. And the market gives a seller very little to price against, because consideration in most Ukrainian transactions is never published. For a shareholder, parent or board no longer certain that continued ownership fits its strategy, risk appetite or capital plan, the published evidence describes an environment rather than an asset.
Transactions are occurring at a modest and reasonably steady scale. KPMG's M&A Radar counted 63 Ukrainian deals above USD 5 million in 2025 against 50 in 2024, with disclosed value of USD 1.2 billion and an average size of USD 34 million. In the first half of 2026 the count rose again, to 40 from 35, while disclosed value eased to USD 978 million. The qualifications matter more to a seller than the direction of travel. Value was disclosed for 57% of deals in 2025 and 45% in the first half of 2026, and KPMG's own methodology records that consideration went unreported for 54% of known Ukrainian transactions between 2013 and 2025, which limits comparison between periods. A separate study by Aequo and Forbes Ukraine, counting deals above USD 5 million where the buyer took at least 10%, puts the 2025 market at USD 1.7 billion across 41 transactions, up from 37 the year before, with five deals accounting for 51% of that volume and two accounting for 47% of the market in the first five months of 2026. The two studies measure different populations rather than contradicting each other. Neither supports a standard Ukrainian multiple, a country discount or a war discount, and an average drawn from so concentrated a distribution says almost nothing about a particular business.
One category is absent from the data altogether. KPMG classifies transactions as domestic, inbound or outbound by reference to the buyer and the target, so the seller is not a variable. A foreign parent selling its Ukrainian subsidiary to a Ukrainian buyer is recorded as a domestic deal. No published dataset counts foreign exits, and claims that foreign companies are leaving Ukraine cannot be tested against transaction statistics.
A harder constraint sits between an agreed price and money reaching the parent. Under the National Bank's wartime currency regime, a non-resident cannot transfer abroad the proceeds of selling Ukrainian corporate rights, securities or property to a domestic buyer. The seller may hold that money in Ukraine but not move it out. Dividends have reopened gradually and within limits, covering profits earned from 1 January 2023, capped at EUR 1 million a month per company and conditional on the company's operating history and the shareholder's holding period. The easing packages that continued through 2026 have extended to dividends, loan servicing and old imports rather than to the return of invested capital.
The same regime contains the exception. It governs transfers out of Ukraine, not payments between non-residents made outside it, and large private deals are frequently executed at the level of holding vehicles outside the country, where a foreign buyer can pay a foreign seller offshore. A sale to a domestic buyer settled in hryvnia and a sale at holding level to a non-resident are therefore economically different transactions for the same business. Buyers price the regime openly. PZU told its own shareholders that the pro forma dividend yield on the Ukrainian acquisition exceeds its current yield even after allowing for the limits on dividends leaving Ukraine.
Who could rationally own the business next therefore shapes both price and payment. In 2025, 40 of the 63 transactions were domestic, with disclosed value of USD 671 million, while inbound volume held flat at 13 deals worth a disclosed USD 232 million. In the first half of 2026 inbound transactions doubled from five to ten and disclosed inbound value rose from USD 26 million to USD 415 million. Domestic buying has also had a specific financial driver. Aequo attributes part of it to hryvnia liquidity accumulating inside large Ukrainian companies that could not pay dividends abroad, citing Kyivstar's cash balances, which grew twelvefold in three years to UAH 20 billion before its run of acquisitions.
The identified buyers describe a narrow population rather than a general market for Ukrainian assets. PZU said it was acquiring market leadership, a distribution network complementary to its existing Ukrainian business, product capability, an experienced team and a customer base. It insured the investment with Poland's export credit agency against war and political risk, and completion depends on clearance by the National Bank and the Antimonopoly Committee, where the same study notes that complex cases can run beyond three months. Bunge, already holding 15% of the oilseed processor ViOil, took the remaining 85% for an estimated USD 138 million, an incumbent extending a position it already understood. When Turkcell sold lifecell, Ukrtower and Global Bilgi to a consortium led by NJJ for USD 524.3 million, the buyer came with EBRD and IFC debt behind it, and eight months passed between signature and completion while approvals were obtained. What a seller can realise depends on what one of these buyers believes it is acquiring, which is the same transaction seen from the other side.
Motive is the part of the record that stays private. Turkcell gave no public reason for its disposal. MetLife has not published its reasoning either, and the same parent agreed to sell its Polish and Greek operations to NN Group for USD 738 million in 2021, before the full-scale invasion. The Ukrainian decision is at least as consistent with a long-running group portfolio review as with anything specific to Ukraine. Inferring a seller's reasons from the date of a transaction is not evidence, and neither is treating every divestment from Ukraine as a verdict on the country.
It follows that weak results are a poor trigger for an ownership decision. MetLife Ukraine was the market leader and profitable when its owner agreed to sell. Where performance is what prompted the review, whether the cause lies in the market, the operating model, execution or management determines whether the answer is repair, redesign or a change of owner, and that diagnosis comes first. National evidence establishes conditions such as demand, energy and labour, financing, regulation and the currency regime. It cannot establish whether one subsidiary should be sold. Sustainable profitability, quality of earnings, capital requirements, customer durability, management dependence and what the operation costs to run without the parent's financing, procurement, systems, guarantees, brand and group customers are company-level facts that no Ukrainian dataset reports. A business that looks profitable inside a group may not be viable standing alone, and buyers test precisely that. KPMG notes growing use of vendor assistance and vendor due diligence, previously uncommon in Ukraine, while Horizon Capital describes preparing assets in advance with an equity story, vendor diligence and early buyer conversations rather than accepting forced exits, because the transaction window is difficult to time.
Retention in a reduced form is an observable option rather than a synonym for inaction. KPMG records 2025 agricultural transactions in which owners sold assets in regions closer to the front line to rebalance geographic exposure while continuing to operate elsewhere, including Agroprosperis disposing of two businesses in Sumy region. A smaller footprint can hold market access, selected customers, licences or an option on recovery, provided the remaining operation still covers its own cost base and does not concentrate risk into fewer customers or fewer people. Once retention is chosen, the problem becomes visibility and decision rights rather than ownership. Winding down deserves the same scrutiny as the alternatives instead of acceptance as the cheap default, since it forfeits sale proceeds and future optionality while consuming cash and management time to discharge obligations. No published Ukrainian evidence shows closure to be faster or cheaper than a sale, and the statutory route belongs with Ukrainian legal, tax and accounting advisers.
Market evidence can establish that Ukrainian businesses are transferable, that buyers cluster among incumbents, regional strategic buyers and financed consortia, that regulators set the timetable, and that settlement structure determines whether proceeds reach the parent or remain in Kyiv. It cannot establish what a specific business is worth or whether anyone will buy it. Selling a business in Ukraine turns on evidence the owner has to produce internally, covering whether the economics and strategic role of the operation have changed structurally or are under temporary pressure, what the business becomes once separated from the group, and whether a credible buyer has an economic reason to own it next. Until those points are settled, the choice between sale, a redesigned footprint and closure is being made between options that have not been tested, and the judgement belongs to the owner or board before any transaction mandate exists.
